The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
The role of type 2 diabetes in neurodegeneration
Open accessAbstract
A growing body of evidence links type-2 diabetes (T2D) with dementia and neurodegenerative diseases such as Alzheimer's disease (AD). AD is the most common form of dementia and is characterised neuropathologically by the accumulation of extracellular beta amyloid (Aβ) peptide aggregates and intracellular hyper-phosphorylated tau protein, which are thought to drive and/or accelerate inflammatory and oxidative stress processes leading to neurodegeneration. Although the precise mechanism remains unclear, T2D can exacerbate these neurodegenerative processes. Brain atrophy, reduced cerebral glucose metabolism and CNS insulin resistance are features of both AD and T2D. Cell culture and animal studies have indicated that the early accumulation of Aβ may play a role in CNS insulin resistance and impaired insulin signalling. From the viewpoint of insulin resistance and impaired insulin signalling in the brain, these are also believed to initiate other aspects of brain injury, including inflammatory and oxidative stress processes. Here we review the clinical and experimental pieces of evidence that link these two chronic diseases of ageing, and discuss underlying mechanisms. The evaluation of treatments for the management of diabetes in preclinical, and clinical studies and trials for AD will also be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–253 of 253
Christopoulos, G., Sexton, P. M., Paxinos, G., Huang, X., Beaumont, K. C., & Toga, A. W. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-146 · Cited by 93
Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease
Kulstad, J. J., Green, P. S., Cook, D. G., Watson, G. S., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Rhoads, K., Mehta, P. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000216274.58185.09 · Cited by 92
Xu, W., Yang, Y., Yuan, G., Zhu, W., Ma, D., & Hu, S. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000129 · Cited by 92
Li, L., Yang, G., Li, Q., Tan, X., Liu, H., Tang, Y., & Boden, G. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00832.x · Cited by 90
Insulin resistance and gray matter volume in neurodegenerative disease
Morris, J. K., Vidoni, E. D., Perea, R. D., Rada, R. C., Johnson, D. K., Lyons, K. E., Pahwa, R., Burns, J. M., & Honea, R. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.006 · Cited by 88
Insulin-degrading Enzyme in Brain Microvessels
Morelli, L., Llovera, R. E., Mathov, I., Lue, L., Frangione, B., Ghiso, J. A., & Castaño, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407283200 · Cited by 86
Liu, W. J., Jin, H. Y., Lee, K. A., Xie, S. H., Baek, H. S., & Park, T. S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01272.x · Cited by 84
Zhou, Q., Lam, P. Y., Han, D., & Cadenas, E. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.02.043 · Cited by 84
Alzheimer’s disease and type 2 diabetes via chronic inflammatory mechanisms
Mushtaq, G., Khan, J. A., Kumosani, T. A., & Kamal, M. A. (2014) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.05.003 · Cited by 80
NMDARs in neurological diseases: a potential therapeutic target
González, J., Jurado-Coronel, J. C., Ávila, M. F., Sabogal, A., Capani, F., & Barreto, G. E. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.940941 · Cited by 80
Kooistra, M., Geerlings, M. I., Mali, W. P. T. M., Vincken, K. L., van der Graaf, Y., & Biessels, G. J. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.06.019 · Cited by 78
GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes
Gao, H., Wang, X., Zhang, Z., Yang, Y., Yang, J., Li, X., & Ning, G. (2007) · Endocrine · doi:10.1007/s12020-007-9011-4 · Cited by 77
Advances in management of type 1 diabetes mellitus
Ravindranath, A., & Jain, V. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.689 · Cited by 77
Inhibition of Aβ production by NF-κB inhibitors
Paris, D., Patel, N., Quadros, A., Linan, M., Bakshi, P., Ait-Ghezala, G., & Mullan, M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.029 · Cited by 75
Hoyer, S., Henneberg, N., KNAPP, S., Lannert, H., & MARTIN, E. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34448.x · Cited by 73
Kimura, R., MacTavish, D., Yang, J., Westaway, D. A., & Jhamandas, J. H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3028-12.2012 · Cited by 70
Alp, H., Varol, S., Çelik, M. M., Altaş, M., Evliyaoğlu, O., Tokgöz, O., Tanrıverdi, M. H., & Uzar, E. (2012) · Experimental Diabetes Research · doi:10.1155/2012/230342 · Cited by 68
Glycemic Status and Brain Injury in Older Individuals
Saczynski, J. S., Siggurdsson, S., Jónsson, P. V., Eiríksdóttir, G., Olafsdottir, E., Kjartansson, Ó., Harris, T. B., van Buchem, M. A., Gudnason, V. G., & Launer, L. J. (2009) · Diabetes Care · doi:10.2337/dc08-2300 · Cited by 68
Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective
Brown, D. X., & Evans, M. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/381713 · Cited by 68
Metabolic triad in brain aging: mitochondria, insulin/IGF-1 signalling and JNK signalling
Yin, F., Jiang, T., & Cadenas, E. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120260 · Cited by 67
Shingo, A. S., Kanabayashi, T., Kito, S., & Murase, T. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.005 · Cited by 65
Chen, S., An, F.-M., Yin, L., Liu, A.-R., Yin, D.-K., Yao, W.-B., & Gao, X.-D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.038 · Cited by 64
Abdallah, D. M., Nassar, N. N., & Abdelsalam, R. M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.007 · Cited by 63
Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor
Xie, L., Martins, R. N., Racchi, M., Craft, S., & Helmerhorst, E. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4504 · Cited by 61
Self-citationJNK: bridging the insulin signaling and inflammatory pathway.
Liu, G., & Rondinone, C. M. (2005) · PubMed · Cited by 59
Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
Wu, L.-Y., Rowley, J., Mohades, S., Leuzy, A., Dauar, M., Shin, M., Fonov, V. S., Jia, J., Gauthier, S., & Rosa-Neto, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047905 · Cited by 54
Bruce, D. G., Davis, W. A., STARKSTEIN, S. E., & Davis, T. M. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132654 · Cited by 52
Okado‐Matsumoto, A., & Fridovich, I. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5385 · Cited by 52
Matrone, C., Djelloul, M., Taglialatela, G., & Perrone, L. (2015) · PubMed · doi:10.14670/hh-30.125 · Cited by 51
Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits
Kummer, M. P., Schwarzenberger, R., Sayah‐Jeanne, S., Dubernet, M., Walczak, R., Hum, D. W., Schwartz, S., Axt, D., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8743-4 · Cited by 49
Antiapoptotic Action of Carbon Monoxide on Cultured Vascular Smooth Muscle Cells
Liu, X., Chapman, G. B., Peyton, K. J., Schafer, A. I., & Durante, W. (2003) · Experimental Biology and Medicine · doi:10.1177/15353702-0322805-30 · Cited by 48
Leal, M. C., Surace, E. I., Holgado, M. P., Ferrari, C. C., Tarelli, R., Pitossi, F. J., Wısnıewskı, T., Castaño, E. M., & Morelli, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.09.014 · Cited by 44
Suh, Y. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00301-3 · Cited by 44
Lessons from two prevalent amyloidoses—what amylin and Aβ have in common
Götz, J., Lim, Y.-A., & Eckert, A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00038 · Cited by 41
Targeting Mitochondrial Biogenesis to Treat Insulin Resistance
Zamora, M., & Villena, J. A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306102514 · Cited by 39
H2O2 Signalling Pathway: A Possible Bridge between Insulin Receptor and Mitochondria
Анатольевич, П. И. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143559 · Cited by 37
Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats
Baraka, A., & Ghotny, S. E. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.030 · Cited by 36
Zhao, Z., Ho, L., Wang, J., Qin, W., Festa, E. D., Mobbs, C., Hof, P., Rocher, A., Masur, S., Haroutunian, V., et al. (2005) · The FASEB Journal · doi:10.1096/fj.05-4359fje · Cited by 36
Effects of amylin on appetite regulation and memory
Flood, J. F., Farr, S. A., Perry, H. M., Kaiser, F. E., Morley, P. M. K., & Morley, J. E. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-147 · Cited by 34
Boland, C. L., DeGeeter, M., Nuzum, D. S., & Tzefos, M. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r444 · Cited by 33
Grunberger, G. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12034 · Cited by 32
Modeling the Effect of Alzheimer's Disease on Mortality
Johnson, E. M., Brookmeyer, R., & Ziegler‐Graham, K. (2007) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1083 · Cited by 31
Gao, W., Eisenhauer, P. B., Conn, K. J., Lynch, J. A., Wells, J. M., Ullman, M. D., McKee, A. C., Thatte, H. S., & Fine, R. E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.034 · Cited by 30
Nakamura, M., & Watanabe, N. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.045 · Cited by 28
Zhao, W., Wu, X., Xie, H., Ke, Y., & Yung, W. (2010) · Neurosignals · doi:10.1159/000324040 · Cited by 28
11β-hydroxysteroid dehydrogenase type I in the brain; thickening the glucocorticoid soup
Yau, J. L. W., & Seckl, J. R. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000967 · Cited by 28
Finding a pathological diagnosis for A lzheimer's disease: Are inflammatory molecules the answer?
Bhamra, M. S., & Ashton, N. J. (2012) · Electrophoresis · doi:10.1002/elps.201200161 · Cited by 26
Liraglutide for the Treatment of Type 2 Diabetes: A Clinical Update
Peters, K. R. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3182204c16 · Cited by 25
Dysglycemia, brain volume and vascular lesions on MRI in a memory clinic population
Exalto, L. G., van der Flier, W. M., Scheltens, P., Vrenken, H., & Biessels, G. J. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.12.003 · Cited by 20
James, D., Kang, S., & Park, S. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-013-0181-z · Cited by 18
Qin, W., & Jia, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06207.x · Cited by 15
H2O2 Signalling Pathway: A Possible Bridge between Insulin Receptor and Mitochondria
Анатольевич, П. И. (2012) · Current Neuropharmacology · doi:10.2174/1570159x11209040311 · Cited by 10
The effects of amylin on motivated behavior in rats
Kovács, A., & Telegdy, G. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02254-6 · Cited by 7
Cited by
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H., & Häring, H.-U. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 622
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Patching, S. G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9672-6 · Cited by 361
Amyloid Beta in Aging and Alzheimer’s Disease
Sehar, U., Rawat, P., Reddy, A. P., Kopel, J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112924 · Cited by 361
Metadata
- Authors
- Verdile, G., Fuller, S. J., & Martins, R. N.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 84
- Pages
- 22-38
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2048294165
- Cited by
- 272
- References
- 253
- FWCI
- 19.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.